|
Volumn 28, Issue 1, 2015, Pages 7-9
|
Spleen Tyrosine Kinase Confers Paclitaxel Resistance in Ovarian Cancer
|
Author keywords
[No Author keywords available]
|
Indexed keywords
CARBOPLATIN;
PACLITAXEL;
PROTEIN KINASE SYK;
OXAZINE DERIVATIVE;
PROTEIN TYROSINE KINASE;
PYRIDINE DERIVATIVE;
SIGNAL PEPTIDE;
ADVANCED CANCER;
CANCER PROGNOSIS;
DRUG MECHANISM;
HUMAN;
MICROTUBULE;
OVARY CANCER;
OVARY CARCINOMA;
PHASE 3 CLINICAL TRIAL (TOPIC);
PRIORITY JOURNAL;
QUALITY OF LIFE;
RANDOMIZED CONTROLLED TRIAL (TOPIC);
SHORT SURVEY;
ANTAGONISTS AND INHIBITORS;
DRUG EFFECTS;
DRUG RESISTANCE;
FEMALE;
OVARIAN NEOPLASMS;
CITRUS MAXIMA;
DRUG RESISTANCE, NEOPLASM;
FEMALE;
HUMANS;
INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS;
MICROTUBULES;
OVARIAN NEOPLASMS;
OXAZINES;
PACLITAXEL;
PROTEIN-TYROSINE KINASES;
PYRIDINES;
|
EID: 84937434540
PISSN: 15356108
EISSN: 18783686
Source Type: Journal
DOI: 10.1016/j.ccell.2015.06.008 Document Type: Short Survey |
Times cited : (17)
|
References (10)
|